Today: 15 May 2026
Browse Category

NASDAQ:GQG 21 November 2025 - 10 December 2025

ASX Biggest Losers Today: Cogstate, Immuron and GQG Partners Lead Australian Stock Market Declines (10 December 2025)

ASX Biggest Losers Today: Cogstate, Immuron and GQG Partners Lead Australian Stock Market Declines (10 December 2025)

Cogstate shares fell over 16% to $2.10 after the company cut profit and revenue guidance, triggering heavy selling. The S&P/ASX 200 hovered near flat by mid-session, masking sharp losses in healthcare, speculative miners, and financials. Immuron plunged 37%, Tusker Minerals dropped 27%, and Janus Electric slid 24%. The 10-year Australian bond yield rose above 4.8%, pressuring growth stocks.
10 December 2025
·····
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

Australian Stock Market Today: ASX 200 Sinks 1.6% as Miners and Banks Lead $40bn Sell‑Off (21 November 2025)

The S&P/ASX 200 closed down 1.6% at 8,416.5 on Friday, erasing nearly $40 billion in value as global tech losses and strong US jobs data spurred heavy selling. Materials and energy stocks led declines, with BHP, Rio Tinto, and Fortescue off 3–3.5%. The index has dropped about 7–8% since its October record. Only consumer staples finished higher.
21 November 2025
········

Stock Market Today

  • Novo Nordisk Stock Review: Mixed Returns Spotlight Valuation Debate
    May 14, 2026, 11:01 PM EDT. Novo Nordisk (NYSE:NVO) shares have presented a mixed performance with a 12.6% decline year to date but a recent 16.5% rebound over the past month. The Danish pharmaceutical giant, known for its Diabetes and Obesity Care products, reported revenues of $327.8 billion and a net income of $121.96 billion. Despite a one-year total shareholder return drop of 28.5%, some analysts see it as 51.8% undervalued with a fair value estimate near $95 per share, almost double its current trading price of $45.80. However, near-term challenges like intensifying competition, pricing pressures, and potential impacts of U.S. pricing reforms on key drugs temper optimism. Investors are urged to weigh these risks alongside durable profit margins and moderated growth forecasts to assess long-term prospects.

Latest articles

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

15 May 2026
The Dow closed above 50,000 for the first time Thursday, rising 370 points as AI-driven gains lifted U.S. stocks to record highs. Cisco surged after raising its revenue outlook and announcing $9 billion in AI infrastructure orders, while Nvidia jumped 4.4% on U.S. approval to sell chips to China. Cerebras Systems soared 68% in its market debut. Not all chipmakers advanced, with Qualcomm, Intel, Sandisk, and Micron falling sharply.
Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

15 May 2026
Xanadu Quantum Technologies reported first-quarter revenue of $2.8 million, up from $0.7 million a year earlier, but net loss widened to $20.6 million. Shares rose 1.9% to $15.13 in late U.S. trading before falling over 3% after hours. The company ended March with $272.5 million in cash and plans a $300 million at-the-market facility. Xanadu began trading on Nasdaq and TSX under XNDU on March 27.
Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

15 May 2026
Sidus Space reported first-quarter revenue of $359,000, up 51% from a year earlier, and a net loss of $5.2 million, narrowing from $6.4 million. Shares rose about 12% after results. Cash stood at $27.3 million at March 31, down from $43.2 million at year-end. The company raised $58.5 million in a direct share offering after the quarter closed.
Google Stock Just Hit a Record. Why Alphabet Shares Slipped Anyway

Google Stock Just Hit a Record. Why Alphabet Shares Slipped Anyway

15 May 2026
Alphabet Class A shares fell 0.4% to $401.07 on Thursday, pausing after a record run even as the S&P 500 and Nasdaq hit new highs. Investors weighed Google’s AI and cloud gains against persistent interest-rate concerns, with profit-taking outweighing news of a new robotics partnership with Fanuc. Alphabet’s market value stood near $4.86 trillion. Google Services revenue rose 16% last quarter, while Google Cloud jumped 63%.
Go toTop